GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: BDM88855 is a bacterial efflux pump inhibitor (EPI), discovered during medicinal chemistry efforts to optimise a series of pyridylpiperazine-based EPIs [2]. BDM88855 has potent activity against the resistance-nodulation-division (RND) family of efflux pumps of Enterobacteriaceae, binding to AcrB, the inner membrane component of the AcrAB-TolC efflux pump [2]. Further structure-based optimisation studies of this lead structure have identified BDM91288, with improved physico-chemical and pharmacokinetic properties [3], and BDM9153, with nanomolar potency [1].
EPIs have potential clinical utility as adjunctive therapeutic agents for the treatment of infections caused by Gram-negative pathogens. |
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
| BDM88855 binds with micromolar affinity to a unique pocket in the transmembrane domain of the AcrB L protomer [2]. It has been postulated that this novel mechanism inhibits drug efflux by allosterically preventing the functional catalytic cycle of the RND pump [2]. |